Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07802964 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of HRS-4139 in Healthy Participants

Name: A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of HRS-4139 in Healthy Participants — clinical trial record (NCT07802964)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorFujian Shengdi Pharmaceutical Co., Ltd.

Started2026-09

View on ClinicalTrials.gov ↗

This Phase I clinical study aims to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral dose of HRS-4139 in healthy participants.

Trial Details

NCT Number	NCT07802964
Lead Sponsor	Fujian Shengdi Pharmaceutical Co., Ltd.
Conditions	Psoriasis Vulgaris
Enrollment	40 participants
Start Date	2026-09
Primary Completion	2027-03 (estimated)
Study Completion	2027-04 (estimated)
Updated on ClinicalTrials.gov	2026-09-03